2023
DOI: 10.3389/fimmu.2023.1251034
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptomic characterization of classical monocytes highlights the involvement of immuno-inflammation in bone erosion in Rheumatoid Arthritis

Lucas Peixoto Sales,
Bidossessi Wilfried Hounkpe,
Mariana Ortega Perez
et al.

Abstract: IntroductionEvidence-based data suggest that under inflammatory conditions, classical monocytes are the main source of osteoclasts and might be involved in bone erosion pathophysiology. Here, we analyze the transcriptomic profile of classical monocytes in erosive and non-erosive rheumatoid arthritis patients in order to better understand their contribution to bone erosion.MethodsThirty-nine premenopausal RA patients were consecutively enrolled and divided into two groups based on the presence of bone erosions … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(15 citation statements)
references
References 35 publications
0
15
0
Order By: Relevance
“…Patients were excluded if they had metabolic bone disease (e.g., rickets, primary hypoparathyroidism, osteomalacia, and Paget’s disease), ii) use of any medication interfering with bone metabolism (e.g., prednisone doses higher than 7.5 mg/day, bisphosphonates, and bone-targeted monoclonal antibodies), iii) other autoimmune disease, or iv) pregnancy or lactation. Premenopausal status was assessed through a self-reported information as previously described ( 10 ). In addition, clinical and transcriptomics data of 17 age- and body mass index-matched healthy subjects were extracted from our previously published database ( 10 ).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…Patients were excluded if they had metabolic bone disease (e.g., rickets, primary hypoparathyroidism, osteomalacia, and Paget’s disease), ii) use of any medication interfering with bone metabolism (e.g., prednisone doses higher than 7.5 mg/day, bisphosphonates, and bone-targeted monoclonal antibodies), iii) other autoimmune disease, or iv) pregnancy or lactation. Premenopausal status was assessed through a self-reported information as previously described ( 10 ). In addition, clinical and transcriptomics data of 17 age- and body mass index-matched healthy subjects were extracted from our previously published database ( 10 ).…”
Section: Methodsmentioning
confidence: 99%
“…Premenopausal status was assessed through a self-reported information as previously described ( 10 ). In addition, clinical and transcriptomics data of 17 age- and body mass index-matched healthy subjects were extracted from our previously published database ( 10 ). The inclusion and exclusion criteria were carefully delineated for the healthy controls group.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations